Effect of Cryolipolysis on Insulin Resistance

Launched by CAIRO UNIVERSITY · Jan 23, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a treatment called cryolipolysis on people with type 2 diabetes who are also obese. Cryolipolysis is a process that cools fat cells to help reduce body fat. The researchers want to see if this treatment can improve insulin resistance, which is when the body doesn’t respond well to insulin, making it harder to control blood sugar levels.

To be eligible for this trial, participants must be women aged 35 to 45 who were diagnosed with diabetes within the last five years and have a fasting blood sugar level higher than 140 mg/dL. They should also have a body mass index (BMI) between 25 and 30, which indicates they are overweight. It's important to note that some people cannot participate, such as those who rely on insulin or have certain health conditions like heart problems or kidney failure. Participants will receive clear explanations about the treatment and can expect to be closely monitored during the study to assess the effects of cryolipolysis on their diabetes management.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patients with incidence of diabetes 5 years ago.
• • Patient fasting glucose level is more than 140 mg/dL.
• • Age will be ranged from 35 to 45 years
• • Body mass index between 25 and 30.
• • All patients are medically controlled
• • All patients have the same medical care.
• • All patients will receive a good explanation of treatment procedures.
• Exclusion Criteria:
• • Patients dependent on insulin.
• • Renal failure.
• • Myocardial infractions.
• • Cardiovascular problems.
• • Neurological disorders.
• • Patients with orthopedic problems (e.g mal or incomplete union of fracture, ankle sprains.
• • Abdominal hernia
• • Skin disease
• • Unstable cases